Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 3,411	$ 4,706
Operating expenses:
Research and development	20,657	12,514
General and administrative	7,084	8,751
Total operating expenses	27,741	21,265
Loss from operations	(24,330)	(16,559)
Other income (expense):
Change in fair value of warrant liability	(337)
Change in fair value of term loan	(1,053)
Interest income	1,693	319
Interest expense	(29)	(1,374)
Other expense	(5)	(8)
Total other income (expense), net	269	(1,063)
Net loss	$ (24,061)	$ (17,622)
Net loss per common share, basic	$ (0.1)	$ (0.28)
Net loss per common share, diluted	$ (0.1)	$ (0.28)
Weighted average common shares outstanding, basic	231,249,344	63,260,905
Weighted average common shares outstanding, diluted	231,249,344	63,260,905